Immatics Appoints Amie Krause as Chief People Officer

Core Insights - Immatics N.V. has appointed Amie Krause as Chief People Officer effective October 27, 2025, to lead human resources and organizational development as the company transitions to a commercial stage [1][2] - The company aims to strengthen its global leadership in precision targeting of PRAME, a target expressed in over 50 cancers, through enhanced organizational excellence and efficiency [2][3] Company Overview - Immatics is a clinical-stage biopharmaceutical company focused on precision targeting of PRAME, with a robust clinical pipeline that includes TCR T-cell therapies and TCR bispecifics [3] - The company is committed to making a meaningful impact on the lives of cancer patients by advancing its PRAME product candidates, including the lead candidate anzu-cel [3] Leadership and Experience - Amie Krause brings over 20 years of experience in organizational growth and talent alignment, having previously held senior HR roles at Dompé, Revance Therapeutics, Atara Biotherapeutics, and Amgen [2] - Krause's background includes leading global commercial operations and serving as an adjunct professor, indicating a strong blend of industry and academic experience [2]